Abstract

Previous studies have demonstrated that microRNA (miRNA) are essential in tumor development and invasion. The close association between focal adhesion kinase (FAK) and colon cancer (CC) has been previously reported. miRNA-7 (miR-7) inhibits the translation of FAK protein. Therefore, the present study aimed to assess the underlying molecular mechanism of miR-7 in human CC cell lines, to provide a novel therapeutic biomarker of CC in the future. The present study detected the expression of miR-7 in 60 CC tissues by reverse transcription-quantitative polymerase chain reaction (RT-qPCR). The association between the expression of miR-7 and clinical pathological factors was analyzed. Overexpression/underexpression of miR-7 were established by transfecting miR-7mimics/inhibitors into HCT-8 and Caco-2 cells. The transfected CC cell lines were used in cell viability and scratching assays. The regulation of FAK by miR-7 was analyzed by western blotting and RT-qPCR. It was demonstrated that the expression of miR-7 negatively correlated with lymph node metastasis and tumor node metastasis staging in CC (P<0.05). Inhibition of miR-7 led to an accelerated ability of proliferation and migration in CC cell lines. Additionally, overexpression of miR-7 inhibited the proliferation and migration of CC cells. In addition, it was also observed that miR-7 regulated the proliferation and migration of CC by regulating the protein expression of FAK, therefore, regulating the expression of matrix metalloproteinase (MMP)-2 and MMP-9. miR-7 inhibited the proliferation and migration of CC cells by regulating FAK. These findings suggested that miR-7 may be a novel therapeutic target for CC.

Highlights

  • Colon cancer (CC) is the second leading cause of cancer‐associated mortality worldwide [1]

  • Results miR‐7 is downregulated in CC and correlates with clinical significance

  • A total of 60 cases of fresh specimens of CC and adjacent normal colon tissues were used to detect the expression of miR‐7 by reverse transcription‐quantitative polymerase chain reaction (RT‐qPCR)

Read more

Summary

Introduction

Colon cancer (CC) is the second leading cause of cancer‐associated mortality worldwide [1]. Invasion is the most difficult problem when treating CC, the molecular mechanism underlying CC invasion remains to be fully elucidated. 10‐25% of patients with CC have been diagnosed with liver metastasis [2,3,4]. The treatments for CC include surgery, chemotherapy, endoscopic stent implant and targeted chemotherapy [5,6]. The most difficult problems for the patients with CC are invasion and metastasis. Detection and targeted therapy are more practical and important for the treatment of CC

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call